(Q35529695)
Statements
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models (English)
Qingshan Wang
Li Qian
Shih-Heng Chen
Chun-Hsien Chu
Belinda Wilson
Esteban Oyarzabal
Syed Ali
Bonnie Robinson
1 reference
1 reference